Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Five-year impact of ICU-acquired neuromuscular complications: a prospective, observational study.

Van Aerde N, Meersseman P, Debaveye Y, Wilmer A, Gunst J, Casaer MP, Bruyninckx F, Wouters PJ, Gosselink R, Van den Berghe G, Hermans G.

Intensive Care Med. 2020 Jan 22. doi: 10.1007/s00134-020-05927-5. [Epub ahead of print]

PMID:
31970446
2.

Performance and potential clinical impact of Alfred60AST (Alifax®) for direct antimicrobial susceptibility testing on positive blood culture bottles.

Van den Poel B, Meersseman P, Debaveye Y, Klak A, Verhaegen J, Desmet S.

Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):53-63. doi: 10.1007/s10096-019-03690-0. Epub 2019 Oct 17.

PMID:
31624985
3.

Bacteriophage Application for Difficult-to-treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol.

Onsea J, Soentjens P, Djebara S, Merabishvili M, Depypere M, Spriet I, De Munter P, Debaveye Y, Nijs S, Vanderschot P, Wagemans J, Pirnay JP, Lavigne R, Metsemakers WJ.

Viruses. 2019 Sep 23;11(10). pii: E891. doi: 10.3390/v11100891.

4.

Five-year mortality and morbidity impact of prolonged versus brief ICU stay: a propensity score matched cohort study.

Hermans G, Van Aerde N, Meersseman P, Van Mechelen H, Debaveye Y, Wilmer A, Gunst J, Casaer MP, Dubois J, Wouters P, Gosselink R, Van den Berghe G.

Thorax. 2019 Nov;74(11):1037-1045. doi: 10.1136/thoraxjnl-2018-213020. Epub 2019 Sep 3.

PMID:
31481633
5.

The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT.

De Vlieger G, Vanhorebeek I, Wouters PJ, Derese I, Casaer MP, Debaveye Y, Hermans G, Meersseman P, Møller HJ, Van den Berghe G, Ingels C.

Crit Care. 2019 Aug 2;23(1):270. doi: 10.1186/s13054-019-2549-8.

6.

Successful use of VV-ECMO in a pregnant patient with severe ARDS.

Carlier L, Muller J, Debaveye Y, Verelst S, Rex S.

Turk J Emerg Med. 2019 May 15;19(3):111-112. doi: 10.1016/j.tjem.2019.04.003. eCollection 2019 Jul.

7.

ACTH and cortisol responses to CRH in acute, subacute, and prolonged critical illness: a randomized, double-blind, placebo-controlled, crossover cohort study.

Peeters B, Meersseman P, Vander Perre S, Wouters PJ, Debaveye Y, Langouche L, Van den Berghe G.

Intensive Care Med. 2018 Dec;44(12):2048-2058. doi: 10.1007/s00134-018-5427-y. Epub 2018 Oct 29.

8.

Adrenocortical function during prolonged critical illness and beyond: a prospective observational study.

Peeters B, Meersseman P, Vander Perre S, Wouters PJ, Vanmarcke D, Debaveye Y, Billen J, Vermeersch P, Langouche L, Van den Berghe G.

Intensive Care Med. 2018 Oct;44(10):1720-1729. doi: 10.1007/s00134-018-5366-7. Epub 2018 Sep 13.

9.

Impact of supplemental parenteral nutrition early during critical illness on invasive fungal infections: a secondary analysis of the EPaNIC randomized controlled trial.

De Vlieger G, Ingels C, Wouters PJ, Debaveye Y, Vanhorebeek I, Wauters J, Wilmer A, Casaer MP, Van den Berghe G.

Clin Microbiol Infect. 2019 Mar;25(3):359-364. doi: 10.1016/j.cmi.2018.05.017. Epub 2018 Jun 2.

10.

Improved survival after LTx-associated acute GVHD with mAb therapy targeting IL2RAb and soluble TNFAb: Single-center experience and systematic review.

Minnee RC, Fieuws S, Jochmans I, Aerts R, Sainz Barriga M, Debaveye Y, Maertens J, Vandenberghe P, Laleman W, van der Merwe S, Verslype C, Cassiman D, Ferdinande P, Nevens F, Pirenne J, Monbaliu D.

Am J Transplant. 2018 Dec;18(12):3007-3020. doi: 10.1111/ajt.14923. Epub 2018 Jun 23.

11.

Early versus Late Parenteral Nutrition in Critically Ill Children.

Fivez T, Kerklaan D, Mesotten D, Verbruggen S, Wouters PJ, Vanhorebeek I, Debaveye Y, Vlasselaers D, Desmet L, Casaer MP, Garcia Guerra G, Hanot J, Joffe A, Tibboel D, Joosten K, Van den Berghe G.

N Engl J Med. 2016 Mar 24;374(12):1111-22. doi: 10.1056/NEJMoa1514762. Epub 2016 Mar 15.

12.

Predictive value for weakness and 1-year mortality of screening electrophysiology tests in the ICU.

Hermans G, Van Mechelen H, Bruyninckx F, Vanhullebusch T, Clerckx B, Meersseman P, Debaveye Y, Casaer MP, Wilmer A, Wouters PJ, Vanhorebeek I, Gosselink R, Van den Berghe G.

Intensive Care Med. 2015 Dec;41(12):2138-48. doi: 10.1007/s00134-015-3979-7. Epub 2015 Aug 13.

PMID:
26266842
13.

Acute outcomes and 1-year mortality of intensive care unit-acquired weakness. A cohort study and propensity-matched analysis.

Hermans G, Van Mechelen H, Clerckx B, Vanhullebusch T, Mesotten D, Wilmer A, Casaer MP, Meersseman P, Debaveye Y, Van Cromphaut S, Wouters PJ, Gosselink R, Van den Berghe G.

Am J Respir Crit Care Med. 2014 Aug 15;190(4):410-20. doi: 10.1164/rccm.201312-2257OC.

PMID:
24825371
14.

Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial.

Hermans G, Casaer MP, Clerckx B, Güiza F, Vanhullebusch T, Derde S, Meersseman P, Derese I, Mesotten D, Wouters PJ, Van Cromphaut S, Debaveye Y, Gosselink R, Gunst J, Wilmer A, Van den Berghe G, Vanhorebeek I.

Lancet Respir Med. 2013 Oct;1(8):621-629. doi: 10.1016/S2213-2600(13)70183-8. Epub 2013 Sep 10.

PMID:
24461665
15.

Withholding parenteral nutrition during critical illness increases plasma bilirubin but lowers the incidence of biliary sludge.

Vanwijngaerden YM, Langouche L, Brunner R, Debaveye Y, Gielen M, Casaer M, Liddle C, Coulter S, Wouters PJ, Wilmer A, Van den Berghe G, Mesotten D.

Hepatology. 2014 Jul;60(1):202-10. doi: 10.1002/hep.26928. Epub 2014 Feb 26.

PMID:
24213952
16.

Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction.

Spriet I, Grootaert V, Meyfroidt G, Debaveye Y, Willems L.

Eur J Clin Pharmacol. 2013 Mar;69(3):737-8. doi: 10.1007/s00228-012-1365-8. Epub 2012 Aug 10. No abstract available.

PMID:
22878691
17.

Augmented renal clearance in the critically ill: how to assess kidney function.

Grootaert V, Willems L, Debaveye Y, Meyfroidt G, Spriet I.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):952-9. doi: 10.1345/aph.1Q708. Epub 2012 Jun 12.

PMID:
22693271
18.

Early versus late parenteral nutrition in critically ill adults.

Casaer MP, Mesotten D, Hermans G, Wouters PJ, Schetz M, Meyfroidt G, Van Cromphaut S, Ingels C, Meersseman P, Muller J, Vlasselaers D, Debaveye Y, Desmet L, Dubois J, Van Assche A, Vanderheyden S, Wilmer A, Van den Berghe G.

N Engl J Med. 2011 Aug 11;365(6):506-17. doi: 10.1056/NEJMoa1102662. Epub 2011 Jun 29.

19.

Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness.

Mebis L, Debaveye Y, Ellger B, Derde S, Ververs EJ, Langouche L, Darras VM, Fliers E, Visser TJ, Van den Berghe G.

Crit Care. 2009;13(5):R147. doi: 10.1186/cc8043. Epub 2009 Sep 11.

20.

Hyperglycemic kidney damage in an animal model of prolonged critical illness.

Vanhorebeek I, Gunst J, Ellger B, Boussemaere M, Lerut E, Debaveye Y, Rabbani N, Thornalley PJ, Schetz M, Van den Berghe G.

Kidney Int. 2009 Sep;76(5):512-20. doi: 10.1038/ki.2009.217. Epub 2009 Jun 17.

21.

Expression of thyroid hormone transporters during critical illness.

Mebis L, Paletta D, Debaveye Y, Ellger B, Langouche L, D'Hoore A, Darras VM, Visser TJ, Van den Berghe G.

Eur J Endocrinol. 2009 Aug;161(2):243-50. doi: 10.1530/EJE-09-0290. Epub 2009 May 13.

PMID:
19439506
22.

Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness.

Vanhorebeek I, Ellger B, De Vos R, Boussemaere M, Debaveye Y, Perre SV, Rabbani N, Thornalley PJ, Van den Berghe G.

Crit Care Med. 2009 Apr;37(4):1355-64. doi: 10.1097/CCM.0b013e31819cec17.

PMID:
19242345
23.

Glucose levels and insulin secretion in surgery-induced hyperglycemia in normoglycemic obese patients.

Michalaki M, Kyriazopoulou V, Mylonas P, Argentou MI, Debaveye Y, Kalfarentzos F, Vagenakis AG.

Obes Surg. 2008 Nov;18(11):1460-6. doi: 10.1007/s11695-008-9501-3. Epub 2008 May 10.

PMID:
18470574
24.

Regulation of tissue iodothyronine deiodinase activity in a model of prolonged critical illness.

Debaveye Y, Ellger B, Mebis L, Darras VM, Van den Berghe G.

Thyroid. 2008 May;18(5):551-60. doi: 10.1089/thy.2007.0287.

PMID:
18466079
25.

Effects of substitution and high-dose thyroid hormone therapy on deiodination, sulfoconjugation, and tissue thyroid hormone levels in prolonged critically ill rabbits.

Debaveye Y, Ellger B, Mebis L, Visser TJ, Darras VM, Van den Berghe G.

Endocrinology. 2008 Aug;149(8):4218-28. doi: 10.1210/en.2007-1566. Epub 2008 May 1.

26.

Modulation of regional nitric oxide metabolism: blood glucose control or insulin?

Ellger B, Langouche L, Richir M, Debaveye Y, Vanhorebeek I, Teerlink T, Van Leeuwen PA, Van den Berghe G.

Intensive Care Med. 2008 Aug;34(8):1525-33. doi: 10.1007/s00134-008-1118-4. Epub 2008 Apr 22. Erratum in: Intensive Care Med. 2008 Sep;34(9):1740. Teerlink, Tom [added].

PMID:
18427775
27.

Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity.

Ellger B, Richir MC, van Leeuwen PA, Debaveye Y, Langouche L, Vanhorebeek I, Teerlink T, Van den Berghe G.

Endocrinology. 2008 Jun;149(6):3148-57. doi: 10.1210/en.2007-1558. Epub 2008 Feb 21.

PMID:
18292189
28.

Changes within the thyroid axis during the course of critical illness.

Mebis L, Debaveye Y, Visser TJ, Van den Berghe G.

Endocrinol Metab Clin North Am. 2006 Dec;35(4):807-21, x. Review.

PMID:
17127148
29.

Risks and benefits of nutritional support during critical illness.

Debaveye Y, Van den Berghe G.

Annu Rev Nutr. 2006;26:513-38. Review.

PMID:
16848718
30.

Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life.

Ingels C, Debaveye Y, Milants I, Buelens E, Peeraer A, Devriendt Y, Vanhoutte T, Van Damme A, Schetz M, Wouters PJ, Van den Berghe G.

Eur Heart J. 2006 Nov;27(22):2716-24. Epub 2006 Apr 11.

PMID:
16608860
31.

Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin.

Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, Herijgers P, Mathieu C, Van den Berghe G.

Diabetes. 2006 Apr;55(4):1096-105.

32.

Changes within the thyroid axis during critical illness.

Peeters RP, Debaveye Y, Fliers E, Visser TJ.

Crit Care Clin. 2006 Jan;22(1):41-55, vi. Review.

PMID:
16399019
33.

Tissue deiodinase activity during prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone-releasing peptide-2.

Debaveye Y, Ellger B, Mebis L, Van Herck E, Coopmans W, Darras V, Van den Berghe G.

Endocrinology. 2005 Dec;146(12):5604-11. Epub 2005 Sep 8.

PMID:
16150898
34.

Endocrine interventions in the ICU.

Ellger B, Debaveye Y, Van den Berghe G.

Eur J Intern Med. 2005 Apr;16(2):71-82.

PMID:
15833672
35.

Is there still a place for dopamine in the modern intensive care unit?

Debaveye YA, Van den Berghe GH.

Anesth Analg. 2004 Feb;98(2):461-8. Review.

PMID:
14742388

Supplemental Content

Loading ...
Support Center